Highlights in Multiple Myeloma from the Annual ASCO and EHA 2022 Meetings
Joshua Richter, MD
Managing Myeloma: Examining the Evidence in Frontline Therapy
Amrita Krishnan, MD, FACP and Saad Z. Usmani, MD, MBA, FACP
Advances and Evolving Standards of Care in Transplant-ineligible NDMM
Saad Z. Usmani, MD, FACP
What has been the overall impact of safety and efficacy in four-drug regimens compared to three-drug regimens?
Sagar Lonial, MD, FACP
FAQ
Developments in Newly Diagnosed Multiple Myeloma:
Considerations for Improved Patient Outcomes
Sagar Lonial, MD, FACP and Saad Z. Usmani, MD, FACP